drugset
Drugs / rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells
last change 30 days ago re-read 2 minutes ago

rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells

Developed for
HIV infectious disease · plasmablastic lymphoma · primary effusion lymphoma
Investigated by
City of Hope Medical Center

Trials 1 · a red edge is where a trial was stopped

today NCT01961063 · Ph 1
20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01961063 Dec 2015 → Aug 2026 overdue HIV infectious disease, plasmablastic lymphoma, primary effusion lymphoma City of Hope Medical Center Active not recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT01961063 ↗
Route Intravenous “rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells IV on day 0” NCT01961063 ↗